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Abstract
Background: Whether myofibers increase with a pulsed-wave mode at particular developmental stages or whether
they augment evenly across developmental stages in large mammals is unclear. Additionally, the molecular
mechanisms of myostatin in myofiber hyperplasia at the fetal stage in sheep remain unknown. Using the first
specialized transcriptome-wide sheep oligo DNA microarray and histological methods, we investigated the gene
expression profile and histological characteristics of developing fetal ovine longissimus muscle in Texel sheep (high
muscle and low fat), as a myostatin model of natural mutation, and Ujumqin sheep (low muscle and high fat).
Fetal skeletal muscles were sampled at 70, 85, 100, 120, and 135 d of gestation.
Results: Myofiber number increased sharply with a pulsed-wave mode at certain developmental stages but was
not augmented evenly across developmental stages in fetal sheep. The surges in myofiber hyperplasia occurred at
85 and 120 d in Texel sheep, whereas a unique proliferative surge appeared at 100 d in Ujumqin sheep. Analysis of
the microarray demonstrated that immune and hematological systems’ development and function, lipid
metabolism, and cell communication were the biological functions that were most differentially expressed
between Texel and Ujumqin sheep during muscle development. Pathways associated with myogenesis and the
proliferation of myoblasts, such as calcium signaling, chemokine (C-X-C motif) receptor 4 signaling, and vascular
endothelial growth factor signaling, were affected significantly at specific fetal stages, which underpinned fetal
myofiber hyperplasia and postnatal muscle hypertrophy. Moreover, we identified some differentially expressed
genes between the two breeds that could be potential myostatin targets for further investigation.
Conclusions: Proliferation of myofibers proceeded in a pulsed-wave mode at particular fetal stages in the sheep.
The myostatin mutation changed the gene expression pattern in skeletal muscle at a transcriptome-wide level,
resulting in variation in myofiber phenotype between Texel and Ujumqin sheep during the second half of
gestation. Our findings provide a novel and dynamic description of the effect of myostatin on skeletal muscle
development, which contributes to understanding the biology of muscle development in large mammals.
Background
Texel sheep, a typical “double muscle” breed due to a
GDF8 mutation [1-3], are now commercially produced
throughout the world, with no adverse effects detected
by objective assessments of meat quality [4]. However,
evidence for an association between g+6723G > A and
decreased intramuscular fat and reduced eating quality
has been observed [5]. Compared with Texel sheep,
indigenous Chinese Ujumqin sheep, with no GDF8
mutation [6], are less muscular and have a higher fat
content, but they are superior in terms of perceived
meat quality. Therefore, these two sheep breeds provide
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opment, as well as for identifying myostatin genes.
Prenatal skeletal muscle development is an important
determinant of both muscularity and meat quality [7].
In large precocial species such as sheep [8,9] and cattle
[10], the maximum myofiber complement of a muscle is
achieved prior to birth. More than three waves of myo-
genic cells appear in sheep, and most myofibers form
during the second half of gestation [11,12]. However,
whether the myofibers increase with a pulsed-wave
mode at certain developmental stages or whether they
augment evenly across developmental stages in fetal
sheep remains unclear.
Myostatin, a member of the transforming growth fac-
tor-b (TGF-b) family, is predominantly expressed and
secreted by skeletal muscle and functions as a negative
regulator of muscle growth. Mutations in the myostatin
gene lead to a hypertrophic phenotype in mice, sheep,
cattle, dog, and human [1,3,5,13-18]. The effect of myos-
tatin on gene expression in prenatal muscles at the gen-
ome-wide level was recently explored in fetal cattle
[19-22], but no studies have been conducted dynami-
cally at multiple fetal stages comparing two pure breeds
with extreme phenotypes. A recent mice study demon-
strated that myoblasts from embryonic and fetal stages
not only had different fusion abilities, proliferation, dif-
ferentiation and responses to TGF-b, phorbol ester 12-
O-tetradecanoylphorbol-13-acetate, and bone morphoge-
netic protein-4 in vitro, but they also differed in gene
expression profiles [23], indicating that complicated and
obvious changes in physiology and biochemistry occur
during the prenatal stage in vivo. Therefore, investigat-
ing the subtle changes of the effect of a myostatin muta-
tion on skeletal muscle development at multiple fetal
stages using our experimental model is necessary.
Here, we examined gene expression and myofiber
development in Texel and Ujumqin sheep at the tran-
scriptome and histological levels. Our findings contri-
bute to understanding the dynamic effects of myostatin
on the biology of prenatal skeletal muscle development
in large mammals. The results also provide clues into
human myopathy and obesity during prenatal stages.
We also identified putative candidate genes that are
valuable for meat-quality traits in farm animals.
Results
Histological characteristics of ovine fetal skeletal muscle
development
We examined the number and diameter of myofibers at
each developmental stage in Texel and Ujumqin sheep
via histological analysis (hematoxylin and eosin [H and
E] staining) (Figures 1 and 2). Significant difference was
observed in myofiber diameter between Texel and
Ujumqin sheep at each development stage, except at 70
d. However, the myofiber diameter patterns of the two
breeds were similar throughout the five developmental
stages.
Unexpectedly, we found that the myofiber hyperplasia
profiles differed between Texel and Ujumqin fetuses
(Figure 2). The proliferation of myofibers in Texel sheep
was fastest at 70 and 85 d, particularly at 85 d, suggest-
ing that this period is vital for muscle development in
Figure 1 Changes in muscle fiber diameter throughout the five
developmental stages in Texel and Ujumqin sheep. Longissimus
dorsi muscle fiber diameter was examined in cross sections using
hematoxylin and eosin staining. At least three animals were used to
analyze each development stage in each breed. Photomicrographs
of five to eight randomly selected areas were used to calculate the
diameter of myofibers in each cross section of muscle examined.
Figure 2 Changes in muscle fiber number throughout the five
developmental stages in Texel and Ujumqin sheep. Longissimus
dorsi muscle fiber number was examined in cross sections using
hematoxylin and eosin staining. At least three animals were used to
analyze each development stage in each breed. Photomicrographs
of five to eight randomly selected areas were used to calculate the
total number of myofibers in each cross section of muscle
examined.
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Page 2 of 18fetal Texel sheep. Myofiber hyperplasia reached a peak
at 100 d in Ujumqin sheep, when the number of myofi-
bers exceeded that of Texel sheep. Notably, with devel-
opment, the number of myofibers in Texel fetuses
recovered to that of Ujumqin fetuses at 120 d, although
myofiber hypertrophy in Texel sheep was greater than
that in Ujumqin sheep at this stage. Therefore, a new
wave of myogenesis most probably occurs at 120 d in
Texel sheep, given that the number of myofibers
increased in Ujumqin sheep during this period.
Additionally, many small-diameter fibers occurred in
the muscle at 135 d in both breeds. The small fibers
could be due either to intrafascicular terminations [24]
or have been generated by the fusion of myoblasts dur-
ing the period investigated. Therefore, to explore the
myogenic potential in the two breeds of sheep, we iden-
tified Pax7-positive cells in skeletal muscle at 135 d
using immnofluorescence staining (IFS) and found that
the ratio of the number of Pax7-positive cells (myoblasts
or satellite cells) to the fibers on each muscle slide was
significantly higher in the Texel fetuses than in the
Ujumqin fetuses (Figure 3). In combination with Figure
2, this observation suggests that a period of 100-120 d is
another new proliferative stage for myofiber hyperplasia
in Texel sheep. Higher numbers of Pax7-positive cells
were correlated with a higher muscle mass in Texel
sheep during both the prenatal and postnatal stages.
Microarray experiment
A mean transcript sequence identity of 97% was found
between ovine and bovine orthologs, which probably
highlights the utility of the microarray technique with
ovine samples [25]. However, some no-reporting probe
sets were found, partly because of the poor performance
of the probe sets with samples from a related species.
The best way to resolve this type of problem is to use a
species-specific microarray. In the present study, we
applied the first specialized and standardized transcrip-
tome-wide sheep oligo DNA microarray (Agilent Sheep
Gene Expression Microarray; Agilent Technologies,
Santa Clara, CA, USA). Due to improvements in species
specificity, the average detectable rate of all probe sets
reached 87.83% (Additional file 1), which enabled us to
capture the subtle changes in gene expression.
A pool of differentially expressed (DE) probes from
the two groups was used for a systematic hierarchical
clustering to gain insight into the transcriptome-wide
similarities among all 31 individuals investigated (Figure
4). We found that individuals at the same developmental
Figure 3 Identification of Pax7-positive cells in longissimus
dorsi muscle by immunofluorescence staining. Longissimus
tissue sections were stained with fluorescent antibodies Pax7
(green) and laminin (red) at 135 d of gestation, respectively. A-D are
the same frozen section stained with the two different fluorescent
antibodies (400×). The corresponding antigens in muscle are
indicated by an arrow (Pax7) and an arrowhead (laminin).
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Figure 4 Hierarchical clustering between the differentially
expressed genes and individuals from the two sheep breeds.
Clustering was performed using GeneSpring 10.0. A one-way
analysis of variance was applied to two within-breed contrasts
across developmental time. A pool of the differentially expressed
probes from the two groups was used for system hierarchical
clustering to clarify the transcriptome-wide similarities among all 31
individuals investigated.
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background, indicating that differences derived during
development were larger than those from the genetic
backgrounds between the breeds.
Gene expression in skeletal muscle at various
developmental stages between breeds
According to the primary functions of different genes
including muscle, lipid, and the immune system, we
visualized the data on MA and bar plots (Figures 5 and
6). Combined with Figures 1 and 2, Figure 6 also sug-
gests the phenotypic profile in muscle and the profile of
a given category of DE genes at different developmental
stages. The biological functions and canonical pathways
were explored at various developmental stages in Texel
and Ujumqin sheep (Tables 1, 2, 3, 4 and 5). The partial
DE genes in the two breeds of sheep at various develop-
mental stages are listed in Tables 6 and 7 (the full set of
differential genes at each developmental stage between
the breeds is listed in Additional files 2, 3, 4, 5 and 6).
T70 vs. U70
The rapid increase in total muscle fiber number in the
ovine fetus begins at 70 d [11,12]. We found that the
number of DE genes was highest at this stage compared
with other stages: 207 probe sets, including 155 known
genes and 50 expressed sequence tags (ESTs) were dif-
ferentially expressed in the T70 and U70 samples. Com-
pared with U70, 82 genes were upregulated and 73
genes were downregulated in T70. A gene ontology ana-
lysis by DAVID revealed that these upregulated genes
encoded cell activation, negative regulation of apoptosis,
positive regulation of peptidyl-tyrosine phosphorylation,
and vesicle-mediated transport. Genes that were down-
regulated encoded hexose catabolism, monosaccharide
catabolism, postembryonic development, alcohol catabo-
lism, and lipid biosynthesis.
To ascertain whether some molecular events or cas-
cades were associated with the process of skeletal mus-
cle development, we identified four canonical pathways
by DAVID and the IPA platforms, which are involved in
myogenesis and muscle metabolism, including the glyco-
lysis/gluconeogenesis pathway, N-glycan biosynthesis,
calcium signaling, and chemokine (C-X-C motif) recep-
tor 4 (CXCR4) signaling).
We also revealed through IPA software that genes
associated with the skeletal and muscular system devel-
opment and function, as well as lipid metabolism, were
top biological functions (Table 1).
 
Figure 5 MA plot for differential genes in Texel and Ujumqin sheep. Genes expressed more highly in Ujumqin sheep are on the bottom,
and genes expressed more highly in Texel sheep are on top. Genes involved in muscles, lipids, and the immune system are denoted by blue
triangles, green circles, and red rectangles, respectively. For example, HLA-DQB1 and AR were highly expressed in Texel, whereas MYL6B was
highly expressed in Ujumqin sheep. Other genes expressed differentially are denoted by gray rectangles.
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eukaryotic translation elongation factor 1 alpha 2
(EEF1A2) was highly expressed in T70. In contrast, the
expression levels of signal transducer and activator of
transcription 3 (STAT3), aldolase A (ALDOA), and the
leptin receptor (LEPR) were upregulated in U70.
T85 vs. U85
In total, 115 probe sets were differentially expressed in
T85 and U85, including 97 annotated genes and 18
ESTs. In contrast to U85, 50 genes were upregulated
and 47 were downregulated in T85. Of these genes,
immune response, cellular carbohydrate catabolism, and
fatty acid metabolism were significantly overrepresented
in the upregulated genes, whereas cell migration regula-
tion was significantly overrepresented in the downregu-
lated genes.
For all DE genes between U85 and T85, we identified
four canonical pathways that were overrepresented
between the two breeds: glycolysis/gluconeogenesis,
fructose and mannose metabolism, the pentose phos-
phate pathway, and vascular endothelial growth factor
(VEGF) signaling. Moreover, hematological system
development and function and lipid metabolism were
still significantly represented as top biofunctions. In par-
ticular, we found a cluster of genes enriched in the bio-
function of skeletal and muscular disorders, suggesting a
difference in skeletal muscle development between
Texel and Ujumqin fetal sheep (Table 2).
Among the DE genes, eukaryotic translation elonga-
tion factor 1 alpha 2 (EEF1A2), fructose-1,6-
bisphosphatase 2 (FBP2), actinin alpha 3, proteoglycan 3
(PRG3), myosin heavy chain 1 (MYH1)w e r em o r e
highly expressed in Texel than in Ujumqin sheep. How-
ever, the stathmin-like 2 (STMN2) and phosphoinosi-
tide-3-kinase, regulatory subunit 1 alpha (PIK3R1)w e r e
more highly expressed in U85.
T100 vs. U100
At this fetal developmental stage, the difference in mus-
cle development, particularly the rate of myofiber prolif-
eration, was most significant between the breeds. Ninety
probe sets, including 70 annotated genes and 20 ESTs,
were differentially expressed in T100 and U100. Among
these genes, 33 were upregulated and 37 were downre-
gulated in T100. The upregulated genes were involved
in DNA binding, RNA binding, and ribonucleoproteins,
whereas those that were downregulated were mostly
related to steroid biosynthesis, lipid metabolism, and
skeletal muscle fiber development.
For all DE genes at 100 d, hematological system devel-
opment and function remained the most overrepre-
sented physiological system, and lipid metabolism was
also more active at this stage. Inositol metabolism, ster-
oid biosynthesis, eukaryotic initiation factor 2 (EIF2) sig-
naling, and VEGF signaling were overrepresented
between T100 and U100 (Table 3).
Within the DE genes, thyroid stimulating hormone
receptor (TSHR)a n dp a r a o x o n a s e1( PON1) were more
highly expressed in Ujumqin sheep than in Texel sheep,
whereas OVAR-DQB1 (sheep MHC class II), pyruvate
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Figure 6 Abundance of primary functional clustering of differentially expressed genes. Counts of genes involved in muscles, lipids, and
the immune system are represented by the ratio of functional categories relative to the total number of genes that exists in the microarray chip
for each of those categories, respectively. The ratio illustrates the abundance of different clusters of differentially expressed genes between Texel
and Ujumqin sheep at five developmental stages (70, 85, 100, 120, and 135 d of gestation).
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Page 5 of 18dehydrogenase kinase, isozyme 4 (PDK4), and thiore-
doxin reductase (TXNRD1) were upregulated in T100.
T120 vs. U120
The discrepancy in fetal muscle development was more
significant between Texel and Ujumqin sheep at 120 d.
In total, 151 probe sets, including 120 annotated genes
and 31 ESTs, were differentially expressed in T120 and
U120. Of these genes, 63 were upregulated in T120 and
57 were upregulated in U120. The upregulated genes
were specific to the immune response, leukocyte activa-
tion, and the I-kappaB kinase/NF-kappaB cascade,
whereas the downregulated genes were significantly
associated with the response to ethanol, the enzyme-
linked receptor protein signaling pathway, and histone
H2A acetylation.
Hematological system development and function,
immune cell trafficking, and nervous system develop-
ment and function were most overrepresented in phy-
siological systems development and function.
Furthermore, lipid metabolism was also the most over-
represented molecular and cellular function. Several
canonical pathways were associated with immune and
lipid metabolism disorders, such as nuclear factor (NF)-
kB signaling and atherosclerosis signaling (Table 4).
Among DE genes between T120 and U120, OVAR-
DQB1 (sheep MHC class II), guanylate-binding protein
2; interferon-inducible, guanylate-binding protein 4; and
Table 1 Summary of the differentially expressed genes between T70 and U70 using IPA
Top Bio Functions
Diseases and Disorders
Name p-value
1 Molecules
2
Cancer
4 5.82E-08-.93E-03 51
Cardiovascular Disease
4 2.61E-06-7.93E-03 19
Developmental Disorder 2.61E-06-7.93E-03 12
Hypersensitivity Response 8.91E-06-7.93E-03 8
Inflammatory Response 1.05E-05-7.93E-03 25
Molecular and Cellular Functions
Name p-value Molecules
Cell-To-Cell Signaling and Interaction 1.77E-06-7.93E-03 32
Cellular Movement 8.91E-06-7.93E-03 25
Lipid Metabolism 9.16E-06-7.93E-03 25
Molecular Transport 9.16E-06-7.93E-03 28
Small Molecule Biochemistry 9.16E-06-7.93E-03 30
Physiological System Development and Function
Name p-value Molecules
Tissue Development 1.77E-06-7.93E-03 24
Hematological System Development and Function 7.13E-06-7.93E-03 22
Hematopoiesis 8.91E-06-7.93E-03 9
Immune Cell Trafficking 8.91E-06-7.93E-03 19
Skeletal and Muscular System Development and Function 2.68E-05-7.93E-03 18
Top Canonical Pathways
Name p-value Ratio
3
Acute Phase Response Signaling 2.2E-03 6/178 (0.034)
Glycolysis/Gluconeogenesis 7.65E-03 4/142 (0.028)
N-Glycan Biosynthesis 9.44E-03 3/93 (0.032)
Calcium Signaling 1.17E-02 5/204 (0.025)
CXCR4 Signaling 3.31-02 4/169 (0.024)
1. The p-value was calculated using a right-tailed Fisher’s exact test. 2. The number of genes enriched in corresponding functions. 3. The ratio was calculated as
the number of genes from our data set that overlap with the canonical pathway in question divided by the total number of genes represented in that canonical
pathway.
4. Italicized terms such as “Cancer“ and “Cardiovascular Disease“ represent a biased annotation or are not related to the aim of the study.
IPA version: 8.7 (release date: 09-17-2010)
Content version: 3202 (release date: 07-07-2010)
Reference set: Ingenuity knowledge base (genes only)
Relationships to include: direct and indirect
Includes endogenous chemicals
Filter summary: Consider all molecules and/or relationships
Ren et al. BMC Genomics 2011, 12:411
http://www.biomedcentral.com/1471-2164/12/411
Page 6 of 18CCAAT/enhancer-binding protein (C/EBP) beta
(CEBPB) were upregulated in T120. Both STMN2 and
transformation/transcription domain-associated protein
(TRRAP) were upregulated in U120.
T135 vs. U135
Seventy-two probe sets, including 58 annotated genes
and 14 ESTs, were differentially expressed in T135 and
U135. Of these genes, 27 were upregulated in T135 and
another 31 were more highly expressed in U135. The
immune response process was overrepresented in the
upregulated genes, and mitosis was represented signifi-
cantly in the downregulated genes.
For the pool of DE genes, embryonic development and
tissue development, hematological system development
and function, cell-mediated immune response, and ner-
vous system development and function were listed at
the top of physiological system development and func-
tion. Cellular functions such as the cell cycle, cell death,
and cell-to-cell signaling and interaction were more
active. Notably, a pathway involved in glycerolipid meta-
bolism was identified between T135 and U135 (Table
5), two members of which (ALDH1A1 and APOC2)
were upregulated in U135.
In terms of physiological system development and
functions, differences in the immune and hematological
systems were most significant between Texlel and
Ujumqin sheep during muscle development. Then, dif-
ferences in nervous system development and function
became more prominent at later gestational stages. The
most obvious differences in molecular and cellular func-
tions were lipid metabolism and cell communication
between the two breeds. Several overrepresented canoni-
cal pathways related to muscle and adipose development
(Table 5), which were particularly noteworthy, under-
pinned the differences in skeletal muscle and adipose
tissue between the two breeds at the fetal stage.
Quantitative PCR validation of microarray gene
expression
To confirm the differential expression of the genes in
the microarray analysis, we selected 15 genes to validate
by quantitative PCR (qPCR). Among these, eight genes
Table 2 Summary of the differentially expressed genes between T85 and U85 using IPA
Top Bio Functions
Diseases and Disorders
Name p-value
1 Molecules
2
Cancer
4 2.37E-07-1.98E-02 35
Inflammatory Response 3.15E-06-2.00E-02 23
Developmental Disorder 1.37E-05-1.94E-02 8
Skeletal and Muscular Disorder 5.76E-05-1.85E-02 33
Genetic Disorder 5.77E-05-2.00E-02 54
Molecular and Cellular Functions
Name p-value Molecules
Cell-To-Cell Signaling and Interaction 3.46E-05-2.00E-02 23
Lipid Metabolism 2.49E-04-2.00E-02 16
Molecular Transport 2.49E-04-2.00E-02 14
Small Molecule Biochemistry 2.49E-04-2.00E-02 18
Drug Metabolism
4 3.71E-04-2.00E-02 5
Physiological System Development and Function
Name p-value Molecules
Hematological System Development and Function 3.46E-05-2.00E-02 17
Endocrine System Development and Function
4 3.71E-04-1.98E-02 5
Visual System Development and Function
4 3.71E-04-3.71E-04 2
Hematopoiesis 3.72E-04-2.00E-02 8
Immune Cell Trafficking 3.72E-04-1.98E-02 16
Top Canonical Pathways
Name p-value Ratio
3
Glycolysis/Gluconeogenesis 1.34E-04 5/142 (0.035)
Fructose and Mannose Metabolism 2.19E-04 4/145 (0.028)
Pentose Phosphate Pathway 9.13E-04 3/89 (0.034)
Dendritic Cell Maturation 1.31E-03 5/188 (0.027)
VEGF Signaling 9.55E-03 3/99 (0.03)
Symbols and analytical settings are the same as in Table 1.
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and TMOD4) encode myofibrillar proteins and two
(EEF1A2 and LEF-1) are transcription factors that regu-
late the genes associated with myogenesis. PIK3R1 is
involved in fat metabolism regulation, whereas TRRAP,
TXNRD1,a n dINSIG1 participate in the regulation of
gene expression and cell proliferation. Additionally, we
also detected MSTN expression during skeletal muscle
development. As in previous studies [26-29], RpLP0 was
chosen as an ideal reference gene to normalize the data.
The ratios of 12 DE genes at particular developmental
stages in the two sheep breeds in the microarray analysis
agreed with the qPCR results (Table 8).
Discussion
Characteristics of prenatal muscle fiber development in
sheep
Wilson et al. and Maier et al. showed that at least three
waves of myogenesis occurred until d 76 of gestation in
sheep [9,11]. We demonstrated that the myofiber num-
bers increase sharply with a pulsed-wave mode at a
particular developmental stage in sheep. This is the first
time that the mode of fetal myofiber proliferation was
revealed in a large mammal during the second half of
gestation. In addition to the longissimus dorsi muscle,
similar patterns of myofiber proliferation were found in
the semitendenosus, gluteus medius, gastrocnemius, and
triceps brachii muscles in Texel and Ujumqin fetal
sheep (data not shown). These findings indicate that the
specific developmental stage during which myogenic
surges of myofiber hyperplasia appeared is pivotal for
fetal muscle development as well as postnatal muscular-
ity potential in sheep.
Unlike the studies of Wilson et al. and Maier et al.,
who identified different generations of myogenic cells
using electron microscopy [9,11], we counted the muscle
fibers under a light microscope and found many small-
diameter fibers until 135 d in both breeds. We consid-
ered that at least part of the small fibers must have
been generated by the fusion of myoblasts (or satellite
cells) during the study period. Pax7 plays an important
role conferring myogenic potential to these progenitor
Table 3 Summary of differentially expressed genes between T100 and U100 using IPA
Top Bio Functions
Diseases and Disorders
Name p-value
1 Molecules
2
Respiratory Disease
4 7.71E-05-2.60E-02 3
Metabolic Disease 1.05E-04-2.51E-02 8
Hypersensitivity Response 2.08E-04-2.51E-02 3
Inflammatory Response 2.08E-04-3.57E-02 11
Cancer
4 5.03E-04-1.92E-02 14
Molecular and Cellular Functions
Name p-value Molecules
Lipid Metabolism 2.91E-11-3.57E-02 16
Small Molecule Biochemistry 2.91E-11-3.57E-02 21
Vitamin and Mineral Metabolism 2.91E-11-2.60E-02 16
Molecular Transport 8.41E-06-3.57E-02 19
Cellular Movement 2.08E-04-3.57E-02 5
Physiological System Development and Function
Name p-value Molecules
Hematological System Development and Function 2.08E-04-3.57E-02 11
Immune Cell Trafficking 2.08E-04-3.57E-02 9
Lymphoid Tissue Structure and Development 2.08E-04-3.57E-02 4
Tissue Development 4.79E-04-3.57E-02 9
Hematopoiesis 6.96E-04-3.57E-02 6
Top Canonical Pathways
Name p-value Ratio
3
T-Helper Cell Differentiation 2E-03 3/72 (0.042)
Inositol Metabolism 3.73E-03 3/97 (0.031)
Biosynthesis of Steroids 5.98E-03 2/128 (0.016)
EIF2 Signaling 3.89E-02 2/103(0.019)
VEGF Signaling 3.98E-02 2/99 (0.02)
Symbols and analytical settings are the same as in Table 1.
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progenitor cells such as myoblasts and satellite cells
[31]. Our findings indicate a higher potential for postna-
tal muscle growth that entails more Pax7-positive cells
in the fetal stage.
Gene expression in the two breeds at various
developmental stages
Of the five prenatal stages, the numbers of DE genes in
the two sheep breeds were highest at 70 and 120 d, indi-
cating that rapid myofiber proliferation included numer-
ous genes during the myogenic process. However, two
surges of myofiber proliferation appeared at 85 and 120
d in Texel fetuses, probably because the expression of
more genes associated with myoblast proliferation and
differentiation at 70 d prepared for the myofiber hyper-
plasia that followed at 85 d, and more genes related to
the immune system were differentially expressed
between T70 and U70 (Figure 6), which led to larger
total counts of DE genes. The difference between the
two sheep breeds in the timing of myogenesis in terms
of transcriptomic levels was similar to that found
between pig breeds [32]. Cagnazzo et al. showed that
myogenesis-related gene expression is greater in early
Duroc (a breed with more intramuscular fat) embryos
than in early Pietrain (a highly muscled breed) embryos
at 14-49 d of gestation, whereas the opposite was found
in late embryos (63-91 d of gestation) [32]. The present
findings suggest that highly muscled breeds have a
longer myogenic process during prenatal stages and that
myogenesis is more intense in late-stage fetuses, which
was validated by Pax7-cell staining in longissimus mus-
cle cross sections (Figure 3). However, whether this
myogenic process is the same in sheep as in pigs at ear-
lier embryonic stages remains to be investigated.
We found that the immune and hematological sys-
tems’ development and function were most overrepre-
sented of all physiological systems and functions,
accompanied by muscle system development, which was
consistent with a microarray developmental analysis in
cattle fetuses [21]. Recent discoveries have revealed
complex interactions between skeletal muscle and the
Table 4 Summary of differentially expressed genes between T120 and U120 using IPA
Top Bio Functions
Diseases and Disorders
Name p-value
1 Molecules
2
Hypersensitivity Response 9.54E-06-1.19E-02 7
Inflammatory Response 9.54E-06-1.19E-02 18
Cancer
4 3.78E-05-1.19E-02 41
Hematological Disease 5.66E-05-1.19E-02 7
Immunological Disease 5.66E-05-1.19E-02 7
Molecular and Cellular Functions
Name p-value Molecules
Cell-To-Cell Signaling and Interaction 9.54E-06-1.19E-02 17
Lipid Metabolism 1.16E-05-1.19E-02 16
Small Molecule Biochemistry 1.16E-05-1.19E-02 20
Carbohydrate Metabolism 3.54E-05-1.19E-02 5
Drug Metabolism
4 3.54E-05-1.19E-02 10
Physiological System Development and Function
Name p-value Molecules
Hematological System Development and Function 9.54E-06-1.19E-02 23
Immune Cell Trafficking 9.54E-06-1.19E-02 13
Nervous System Development and Function 1.69E-05-1.19E-02 8
Tissue Development 1.69E-05-1.19E-02 13
Reproductive System Development and Function
4 7.17E-05-1.19E-02 10
Top Canonical Pathways
Name p-value Ratio
3
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis
4 1.54E-04 5/91 (0.055)
NF-kB Signaling 1.87E-03 5/155 (0.032)
Autoimmune Thyroid Disease Signaling 2.77E-03 3/61 (0.049)
Atherosclerosis Signaling
4 2.92E-03 4/113 (0.035)
Taurine and Hypotaurine Metabolism 3.53E-03 2/47 (0.043)
Symbols and analytical settings are the same as in Table 1.
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myogenesis, and many immune molecules, such as
tumor necrosis factor-alpha (TNF-a), NF-kB, interleukin
(IL)-4, IL-6, IL-10, and leuk e m i ai n h i b i t o r yf a c t o ra r e
involved in muscle cell proliferation and differentiation
[33-38]. In most cases, whether perturbation in the
same signaling pathways related to myogenesis occurs
will determine normal myogenic development or muscle
disorders. Therefore, the pathways associated with
immune and muscle disorders in this work are valuable
for human myopathy at the prenatal stage. The hemato-
logical system is also implicated in myogenesis [39-43],
which probably reflects the systemic requirement for
muscle function during fetal development.
Nervous system development was overrepresented in
the last two development stages in the two sheep breeds.
Neurons are indispensable for maintaining normal mus-
cle physiological function and also parallel the skeletal
muscle in auxology. Comprehensive and close interac-
tions occur between muscles and the nervous system
during development [44-46]. Muscle development is
regulated by the central nervous system in Drosophila
and pigs [47,48], and muscle fiber type is dependent on
the pattern of innervation of a muscle established due
to differential projection patterns between fast and slow
motoneurons [49,50]. Animals with different muscle
phenotypes undergo diverse innervation patterns during
fetal development. Double-muscled cattle have an addi-
tional 13-26% increased branching in terminal axons
compared to that in normal cattle caused by a real
increase in the number of myofibers [51].
We identified several valuable canonical pathways
directly associated with muscle development and func-
tion, myogenesis, myoblast proliferation, and the cell
cycle in muscle at various developmental stages, such as
calcium [52], CXCR4 [53-55], and VEGF signaling [56].
Furthermore, other pathways involved in adipose and
muscle metabolism, such as inositol metabolism, steroid
biosynthesis, EIF2 signaling, glycerolipid metabolism, the
glycolysis/gluconeogenesis pathway, and N-glycan bio-
synthesis, are significantly affected during development.
Steelman et al. suggested that Wnt signaling is a
Table 5 Summary of differentially expressed genes between T135 and U135 using IPA
Top Bio Functions
Diseases and Disorders
Name p-value
1 Molecules
2
Cancer
4 9.23E-06-2.87E-02 7
Reproductive System Disease
4 9.23E-06-6.44E-03 7
Genetic Disorder 3.22E-03-2.87E-02 5
Immunological Disease 3.22E-03-3.22E-03 1
Infection Mechanism 3.22E-03-4.11E-02 4
Molecular and Cellular Functions
Name p-value Molecules
Cell Cycle 5.50E-04-2.87E-02 3
Cell Death 1.04E-03-2.43E-02 8
Cell-To-Cell Signaling and Interaction 3.22E-03-4.42E-02 5
Cellular Assembly and Organization 3.22E-03-4.42E-02 7
Cellular Compromise 3.22E-03-4.42E-02 3
Physiological System Development and Function
Name p-value Molecules
Embryonic Development 5.50E-04-2.55E-02 5
Tissue Development 5.50E-04-4.11E-02 7
Hematological System Development and Function 2.47E-03-4.42E-02 7
Cell-mediated Immune Response 3.22E-03-4.42E-02 2
Nervous System Development and Function 3.22E-03-6.44E-03 2
Top Canonical Pathways
Name p-value Ratio
3
LPS/IL-1-mediated Inhibition of RXR Function 3.61E-03 4/216 (0.019)
Histidine Metabolism 1.26E-02 2/120 (0.017)
PXR/RXR Activation 2.2E-02 2/91 (0.022)
Arginine and Proline Metabolism 2.68E-02 2/183 (0.011)
Glycerolipid Metabolism 4.51E-02 2/156 (0.013)
Symbols and analytical settings are the same as in Table 1.
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Page 10 of 18potential downstream target of myostatin for postnatal
skeletal muscle growth and hypertrophy in mice [57].
However, we focused on the transcriptome during pre-
natal stages rather than postnatal stages and found that
various canonical pathways are predominant in skeletal
muscle development at different stages due to a myosta-
tin mutation in sheep.
DE genes involved in muscle and adipose development
STAT3, a member of the STAT family and a cooperator
in the Janus kinase pathway, plays a dual role in the reg-
ulation of myoblast proliferation and differentiation, but
is dependent on interactions with various cofactors
[58-62]. We found that STAT3 expression was higher in
U70 than T70, which suggests that STAT3 is most prob-
ably associated with the differentiation rather than pro-
liferation of myoblasts. The GO analysis of DE genes
between T70 and U70 confirmed our presumption, and
muscle fiber hyperplasia was more intense in T70 (Fig-
ure 2) as well.
ALDOA is responsible for significant activation during
the differentiation of chicken primary myoblasts and
plays an important role in muscle gene transcription
[63,64]. In our study, a higher ALDOA expression level
in U70 indicated that more myoblasts exited the cell
cycle and entered differentiation in U70 than those in
T70. The leptin receptor (LEPR), a protein secreted
from adipocytes, is responsible for fat mass regulation
Table 6 Examples of downregulated genes between Texel and Ujumqin sheep at the same developmental stage
Probe Name Genbank Accession
Number
Gene Fold
Change
Developmental
stage
A_70_P069356 EE752033 Homo sapiens selenoprotein I (SELI) 15.35 70 d
A_70_P016291 EE793140 Homo sapiens Rho-related BTB domain containing 3 (RHOBTB3) 5.16 70 d
A_70_P006561 EE781286 Homo sapiens nucleolar protein 7 (NOL7) 4.54 70 d
A_70_P004621 EE863207 Homo sapiens signal transducer and activator of transcription 3 (STAT3) 2.38 70 d
A_70_P001706 FE033261 Homo sapiens aldolase A, fructose-bisphosphate, transcript variant 1 (ALDOA) 2.28 70 d
A_70_P056812 NM_001009763 Homo sapiens leptin receptor (LEPR) 2.24 70 d
A_70_P005526 CO202686 Homo sapiens stathmin-like 2 (STMN2) 8.23 85 d
A_70_P016291 EE793140 Homo sapiens Rho-related BTB domain containing 3 (RHOBTB3) 5.99 85 d
A_70_P068196 EE779349 Homo sapiens trefoil factor 3 (TFF3) 5.19 85 d
A_70_P039551 NM_001009266 Homo sapiens proopiomelanocortin (POMC) 5.00 85 d
A_70_P037096 EE773353 Homo sapiens phosphoinositide-3-kinase, regulatory subunit 1 (alpha) (PIK3R1),
transcript variant 2
2.77 85 d
A_70_P001731 EE780294 Homo sapiens trafficking protein, kinesin-binding 1 (TRAK1) 8.04 100 d
A_70_P017916 EE828626 Homo sapiens S100 calcium-binding protein A11(S100A11) 8.03 100 d
A_70_P032741 CF116713 Bos taurus defensin, beta (DEFB) 7.09 100 d
A_70_P001411 EE873259 Bos taurus secretoglobin, family 1D, member 2 (SCGB1D2) 5.59 100 d
A_70_P039326 NM_001009410 Homo sapiens thyroid-stimulating hormone receptor (TSHR) 4.50 100 d
A_70_P045271 EE788300 Homo sapiens paraoxonase 1 (PON1) 4.01 100 d
A_70_P068131 DQ152973 Homo sapiens lymphoid enhancer-binding factor1 (LEF-1) 2.23 100 d
A_70_P035741 FE033512 Bos taurus X (inactive)-specific transcript (XIST), noncoding RNA 65.59 120 d
A_70_P005526 CO202686 Homo sapiens stathmin-like 2 (STMN2) 21.27 120 d
A_70_P018856 EE791277 Homo sapiens ATP-binding cassette, subfamily B (MDR/TAP), member 4
(ABCB4)
15.37 120 d
A_70_P024811 EE777383 Homo sapiens epithelial cell adhesion molecule (EPCAM) 7.16 120 d
A_70_P019481 EE828813 Homo sapiens transformation/transcription domain-associated protein (TRRAP) 4.92 120 d
A_70_P030147 NM_001009261 Homo sapiens prion protein 2 (doublet) (PRND) 4.84 120 d
A_70_P025536 FE022583 Homo sapiens glutamate receptor, metabotropic 8 (GRM8) 4.62 120 d
A_70_P051317 NM_001009479 Homo sapiens natriuretic peptide precursor C (NPPC) 4.46 120 d
A_70_P030402 NM_001093787 Homo sapiens kallikrein 1 human (KLK1) 4.37 120 d
A_70_P051037 NM_001009451 Homo sapiens solute carrier family 2 (facilitated glucose/fructose transporter),
member 5 (SLC2A5)
8.14 135 d
A_70_P035536 DY520412 Homo sapiens ankyrin repeat domain 1 (cardiac muscle) (ANKRD1) 5.37 135 d
A_70_P016291 EE793140 Homo sapiens Rho-related BTB domain containing 3 (RHOBTB3) 4.14 135 d
Differentially expressed probes were detected from five t-test analyses using GeneSpring 10.0 (Agilent Technologies).
1. Original probe name in microarray analysis. 2. GenBank Accession Number of expressed sequence tags provided by the manufacturer according to the specific
probe name. 3. The highly homologous human sequences acquired using BLASTN search in NCBI (search setting: query coverage not less than 50%, E-value less
than 1.00E-100).
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was higher in U70 than in T70. Whether the higher
LEPR expression at prenatal stages is associated with
high postnatal adipose deposition remains to be
investigated.
Both hyperplasia and hypertrophy continued in skele-
tal muscle at 85 d. FBP2, which encodes a gluconeogen-
esis regulatory enzyme that catalyzes the hydrolysis of
fructose 1,6-bisphosphate to fructose 6-phosphate and
inorganic phosphate, was expressed higher in T85 than
in U85. A previous study suggested that FBPase partici-
pates in some nuclear processes during the development
and regeneration of skeletal muscle [67,68]. Additionally,
PRG3 expression was also higher in T85. Previous stu-
dies have shown that PRG3 plays a role in some early
aspects of skeletal myogenesis [69-72].
The expression levels of PIK3R1, TSHR,a n dPON1
were higher in U85 and U100 than that in T85 or T100.
Table 7 Examples of upregulated genes between Texel and Ujumqin sheep at the same developmental stage
Probe Name
1 GenBank
2 Accession
Number
Gene
3 Fold
Change
Developmental
Stage
A_70_P046666 EE795873 Homo sapiens eukaryotic translation elongation factor 1 alpha 2 (EEF1A2) 8.92 70 d
A_70_P011966 FE031658 Homo sapiens transmembrane channel-like protein 5 (TMC5) 6.74 70 d
A_70_P019721 EE787688 Homo sapiens complement component 4-binding protein, alpha (C4BPA) 6.64 70 d
A_70_P024986 EE825499 Homo sapiens CD8a molecule, complete cds (CD8A) 6.06 70 d
A_70_P003451 CU652121 Homo sapiens cardiomyopathy-associated 5 (CMYA5) 4.09 70 d
A_70_P046666 EE795873 Homo sapiens eukaryotic translation elongation factor 1 alpha 2 (EEF1A2) 16.21 85 d
A_70_P063416 EE775784 Homo sapiens fructose-1,6-bisphosphatase 2 (FBP2) 10.39 85 d
A_70_P037371 EE776937 Homo sapiens actinin, alpha 3 (ACTN3) 7.83 85 d
A_70_P054756 EE791183 Homo sapiens apolipoprotein C-II (APOC2) 6.29 85 d
A_70_P055056 EE768552 Homo sapiens proteoglycan 3 (PRG3) 6.03 85 d
A_70_P050846 CU651713 Homo sapiens myosin, heavy chain 1, skeletal muscle, adult (MYH1) 5.60 85 d
A_70_P019721 EE787688 Homo sapiens complement component 4-binding protein, alpha (C4BPA) 4.00 85 d
A_70_P017031 L08792 Homo sapiens major histocompatibility complex, class II, DQ beta 1 (HLA-
DQB1)
131.77 100 d
A_70_P044801 EE862627 Homo sapiens chemokine ligand 26-like protein (CCL26) 10.16 100 d
A_70_P024246 EE859238 Homo sapiens pyruvate dehydrogenase kinase, isozyme 4 (PDK4) 5.85 100 d
A_70_P057421 EE784201 Homo sapiens MAK16 homolog (S. cerevisiae) (MAK16) 5.22 100 d
A_70_P070736 EE824836 Homo sapiens thioredoxin reductase mRNA (TXNRD1) 5.20 100 d
A_70_P011371 EE813532 Homo sapiens isopentenyl-diphosphate delta isomerase 1 (IDI1) 4.25 100 d
A_70_P017031 L08792 Homo sapiens major histocompatibility complex, class II, DQ beta 1 (HLA-
DQB1)
1389.16 120 d
A_70_P066011 FE028749 Homo sapiens ubiquitin-specific peptidase 9, Y-linked (USP9Y) 670.44 120 d
A_70_P066386 EE851120 Homo sapiens guanylate-binding protein 2, interferon-inducible (GBP2) 76.81 120 d
A_70_P052621 EE778111 Homo sapiens pyrophosphatase (inorganic) 1 (PPA1) 14.06 120 d
A_70_P065251 EE748701 Homo sapiens CD48 molecule (CD48) 9.68 120 d
A_70_P044801 EE862627 Homo sapiens chemokine ligand 26-like protein (CCL26) 7.26 120 d
A_70_P035891 EE805356 Homo sapiens sorting nexin 10 (SNX10) 5.93 120 d
A_70_P000126 EE807554 Homo sapiens guanylate-binding protein 4 (GBP4) 4.97 120 d
A_70_P016471 EE829459 Homo sapiens N-myc upstream-regulated 1 (NDRG1) 4.40 120 d
A_70_P039346 NM_001009789 Homo sapiens prostaglandin F receptor (FP) (PTGFR) 4.32 120 d
A_70_P011531 EE776172 Homo sapiens CCAAT/enhancer-binding protein (C/EBP), beta (CEBPB) 4.14 120 d
A_70_P045436 EE827672 Homo sapiens glutathione S-transferase theta 1 (GSTT1) 4.13 120 d
A_70_P025036 EE746884 Homo sapiens regulator of G-protein signaling 1 (RGS1) 11.22 135 d
A_70_P049266 EE815004 Bos taurus mRNA for T-cell receptor alpha chain, leader sequence, variable and
joining region (TRA2)
7.06 135 d
A_70_P030156 NM_001009735 Homo sapiens ISG15 ubiquitin-like modifier (ISG15) 4.28 135 d
A_70_P030132 NM_001104930 Homo sapiens receptor (chemosensory) transporter protein 4 (RTP4) 4.20 135 d
A_70_P001016 FE027322 Homo sapiens eukaryotic translation initiation factor 2, subunit 2 beta (EIF2S2) 3.52 135 d
Differentially expressed probes were detected from five t-test analyses using GeneSpring 10.0 (Agilent Technologies).
1. Original probe name in the microarray analysis. 2. The GenBank Accession Number of expressed sequence tags provided by the manufacturer according to the
specific probe name. 3. The highly homologous human sequences acquired by a BLASTN search in NCBI (search setting: query coverage not less than 50%, E-
value less than 1.00E-100).
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involved in fat metabolism and adipocyte development
[73-76].
PDK4, a gene that was upregulated in T100, is a key
regulatory enzyme involved in switching the energy
source from glucose to fatty acids in response to physio-
logical conditions. The pyruvate dehydrogenase complex
occupies a central and strategic position in muscle inter-
mediary metabolism and is primarily regulated by phos-
phorylation/dephosphorylation [77]. In addition, PDK4
is significantly associated with intramuscular fat and
muscle water content [78], indicating that PDK4 is
involved in meat quality.
TXNRD1 is a variant of thioredoxin reductase, an
important selenoprotein that maintains cellular redox
balance and regulates several redox-dependent processes
during apoptosis, cell proliferation, and differentiation
[79-81]. LEF1 is a transcription factor involved in the
regulation of myogenesis. Loss of Lef1-mediated repres-
sion results in an increased number of cells expressing
Pax-7 and Pax-3, suggesting that Wnt signaling via Lef1
acts to regulate the number of premyogenic cells in
somites [82]. In our study, LEF1 expression was higher
in U100 than that in T100, which is consistent with the
rapid proliferation of myofibers in U100. Although tran-
scription factor activity is predominantly manifested at
the protein level, the difference in LEF1 expression level
indicated a potential difference of LEF1 between breeds.
OVAR-DQB1 (sheep MHC class II) was expressed
much higher in T100 and T120, particularly in T120
(Table 7), compared with U 100 and U120. Results from
Karpati et al. indicated that the class I molecule may be
involved in the fusion of myogenic cells during muscle
regeneration [83]. Honda and Rostami demonstrated
that the expression of class I antigens on muscle cells is
not only immunologically modulated but also develop-
mentally regulated, and that these antigens may play a
role in cell recognition and interaction during the myo-
genic fusion process. The presence of the antigens, how-
ever, was transitory, and they disappeared as myoblasts
fused and differentiated into multinucleate myotubes
[84].
CEBPB, an important transcription factor, acts as a
indispensable regulator of adipocyte differentiation dur-
ing adipogenesis [85-87]. We found that CEBPB expres-
sion was higher in skeletal muscle in T120 than in
U120, indicating a key difference in adipogenesis
between Texel and Ujumqin sheep. However, which
breeds contain more adipose mass than the other at this
developmental stage remains to be investigated.
TRRAP, which was downregulated in T120, in contrast
to that in U120, is vital for embryonic survival and con-
trol of the mitotic checkpoint [88-91]. Deletion of
TRRAP leads to a reduced level of beta-catenin ubiquiti-
nation, a lower degradation rate, and accumulation of
the beta-catenin protein, whereas TRRAP knockdown
results in abnormal retention of beta-catenin at chroma-
tin and concomitant hyperactivation of the canonical
Wnt pathway [92]. However, the canonical Wnt path-
way is downregulated in the absence of myostatin
through beta-catenin, whereas the Wnt/calcium pathway
is upregulated [57], suggesting that TRRAP may nega-
tively regulate skeletal muscle development between the
canonical Wnt and the Wnt/calcium pathways through
beta-catenin at 120 d. Further efforts are warranted to
Table 8 Validation of differential expression by
quantitative PCR (qPCR)
Ratio of gene expression between two sheep
breeds
1
Gene Method T70/
U70
T85/
U85
T100/
U100
T120/
U120
T135/
U135
EEF1A2 qPCR 0.23 1.36 4.17 0.57 0.11
microarray 8.92 16.21* 1.78 0.78 0.98
TXNRD1 qPCR 131.73 382.54 35.06 2.3 1.16
microarray 1.38 1.14 5.20* 3.15 0.94
INSIG1 qPCR 0.82 1.65 0.32 0.16 0.10
microarray 1.10 1.11 0.34* 0.88 0.87
LEF-1 qPCR 6.64 21.65 0.51 0.78 0.16
microarray 0.52 0.59 0.47* 0.50 0.57
TMOD4 qPCR 81.5 714.32 323.03 3.7 0.02
microarray 2.80* 3.52* 1.54 1.15 0.80
TPM2 qPCR 0.29 0.87 1.48 0.17 0.84
microarray 0.48* 0.60 1.54 3.03 1.10
MYO9A qPCR 0.14 0.15 0.25 0.31 0.12
microarray 0.49* 0.61 1.02 0.75 1.20
TRRAP qPCR 0.06 0.30 0.85 1.11 0.42
microarray 0.51 0.35 1.79 0.20* 0.26
TNC qPCR 0.21 0.54 5.12 6.23 10.46
microarray 0.88 0.69 0.41* 0.62 1.78
PIK3R1 qPCR 0.61 0.44 0.23 1.06 0.29
microarray 0.51 0.36* 1.03 1.92 1.14
ACTB qPCR 1.79 0.16 0.73 0.35 0.85
microarray 1.09 0.55 0.48* 1.39 0.47
MYL6B qPCR 0.35 1.0 3.44 0.84 0.85
microarray 0.42* 1.14 0.88 1.16 1.04
MYH1 qPCR 0.84 1.36 0.21 0.57 0.56
microarray 1.89 5.60* 1.56 1.19 1.09
CASQ1 qPCR 0.51 0.76 0.56 0.07 2.79
microarray 2.16 * 2.31 1.23 0.82 0.72
MSTN qPCR 0.81 0.71 0.54 0.47 0.61
microarray 0.69 0.92 0.62 0.56 0.81
1. The data in the rows are the ratio of the 2
ΔΔCT values for the qPCR in a
Texel sheep sample relative to that in the Ujumqin sheep sample at the same
developmental stage. The microarray row provides gene expression ratios in
Texel sheep samples divided by those in Ujumqin sheep samples at the same
developmental stage. *Differentially expressed genes in the microarray
analysis with a statistically significant difference at p < 0.05.
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development.
Other than the genes discussed above, we found that
MSTN expression was lower in Texel than in Ujumqin
sheep through the five development stages (Table 8).
This result indicated that MSTN downregulation con-
tributed to the hyperplasia and hypertrophy of myofibers
in Texel sheep through the second half of gestation.
Moreover, the genes discussed above are potential
myostatin targets for further investigation.
Conclusions
We demonstrated that fetal myofiber number increased
sharply in a pulsed-wave mode at a particular develop-
mental stage and was not augmented evenly across
developmental stages in large mammal. The two surges
in myofiber hyperplasia occurred at 85 and 120 d in
Texel sheep, whereas a single surge appeared at 100 d
in Ujumqin sheep during the second half of gestation. A
myostatin mutation changed the gene expression profile
in prenatal skeletal muscle, particularly disrupting some
pivotal signaling pathways governing muscle develop-
ment and function at some developmental stages, which
explains much of the variation in myofiber phenotypes
between Texel and Ujumqin sheep. Further studies on
the crucial DE genes and signaling pathways involved
would be helpful for revealing the mystery of muscle
development in mammals.
Methods
Animals
All experimental and surgical procedures were approved
by the Biological Studies Animal Care and Use Commit-
tee, Shanxi Province, Peoples Republic of China.
Seventy-eight Ujumqin and 54 Texel ewes were pre-
pared. These purebred female animals involved were
selected based on their age (3-5 years old), body weight
(50-55 kg), and body size. After these animals were sub-
jected to pre-feeding for 45 days, estrus was synchro-
nized in all ewes using an implanted controlled internal
drug release device (Pharmacia & Upjohn Pty Limited,
Parramatta City, NSW, Australia) and intramuscular
injections of pregnant mare serum gonadotropin
(Ningbo Renjian Pharmaceutical Co., Ltd, Zhejiang,
China), according to the manufacturers’ protocol, fol-
lowed by artificial insemination using the corresponding
breed sire’s sperm. Three pregnant ewes from each
breed were subject to caesarean section to collect the
fetuses at 70, 85, 100, 120, and 135 d of gestation, and
then the 12 different anatomic skeletal muscles from
each fetus were dissected and weighed (longissimus
dorsi, semitendenosus, semimembranosus, gluteus med-
ius, femoral quadriceps, gastrocnemius, serratus ventralis
thoracis muscle, biceps femoris, adductor, supraspinatus,
infraspinatus, and triceps brachii). Two samples were
taken from each muscle at standardized anatomical
sites. The first sample (3 g) was dissected and rapidly
frozen whole in isopentane chilled over liquid nitrogen
for histological examination. The second sample (5 g)
was snap-frozen in liquid nitrogen for gene expression
analysis.
Histology analysis
To examine the development of skeletal muscle in both
sheep breeds, we measured the number and the dia-
meter of the longissimus dorsi muscle fiber in Ujumqin
and Texel sheep during five development stages using
hematoxylin and eosin staining. Serial cross sections of
10 μm thickness were cut at -20°C using a cryostat.
Photomicrographs of five to eight randomly selected
areas were used to estimate the the diameter and the
total number of myofibers in the cross sections of mus-
cle examined. Muscle fiber measurements were con-
ducted using DT2000 (V2.0) image analysis software
(Nanjing East-image Ltd., Nanjing, China).
The primary IFS antibodies were rabbit-laminin anti-
body (Sigma, St. Louis, MO, USA) and mouse monoclo-
nal anti-pax7 (Developmental Studies Hybridoma Bank,
University of Iowa, Iowa City, IA, USA). The corre-
sponding secondary antibodies were anti-mouse immu-
noglobulin (ALEXA488) and anti-rabbit
immunoglobulin (ALEXA594) (Invitrogen, Carlsbad,
CA, USA). Staining was performed according to the
manufacturer’s instructions. The IFS slides were ana-
lyzed using a system of epi-fluorescence microscopes
( T E 2 0 0 0 U ;N i k o n ,T o k y o ,J a p an). The satellite cell (SC)
nuclei were stained green and the basal lamina, red.
Images were subsequently analyzed using Image Pro
Plus (v5.1) image analysis software (Media Cybernetics,
Inc., Bethesda, MD, USA). The numbers of SCs and
myofibers in each section were counted, and the SC
concentration within a given area of view was also cal-
culated for each slide.
Data between the two breeds were analyzed using the
t-test procedure in SPSS 13.0 (SPSS, Inc., Chicago, IL,
USA). A p-value of < 0.05 was considered statistically
significant.
Microarray experiment
We made five independent comparisons at the same
development stages in both breeds using a t-test and
detected 207, 115, 90, 151, and 72 DE probes with a
greater than twofold change at 70, 85, 100, 120, and 135
d of gestation, respectively. The new specialized and
standardized transcriptome-wide sheep microarray (Agi-
lent Technologies) contained 15,008 sheep probes
sourced from RefSeq and UniGene. The oligo microar-
ray was 15 K in size. The longissimus dorsi muscles
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sion. The microarray of each development stage for
each breed contained three biological replicates (n = 3)
except the T100 team (n = 4). Thus, 31 hybridizations
in total were performed. Data were deposited in the
NCBI database (GSE23563).
Total RNA was extracted from the frozen longissimus
dorsi muscles using an RNeasy Mini Kit with DNase
treatment (Qiagen, Valencia, CA, USA) according to the
manufacturer’s protocol. The total RNA from each indi-
vidual was labeled with Cy3 fluorescence. The generated
targets were mixed and subjected to hybridization with
the Sheep Gene Expression Microarray (Agilent Tech-
nologies), according to the manufacturer’s protocol.
Scanning of the microarrays was performed using a
DNA microarray scanner (Agilent Technologies). The
scanning parameters were a 5 μm scan resolution, PMT
with 100%, and 10% once, respectively. All probe sets
whose signals were reported as “absent” during the flag
call in all 31 arrays were filtered out, and those from
probe sets called “present” on at least one chip were
used for further analysis. Scanner output image files
were normalized and filtered using Feature Extraction
Software v10.5 (Agilent Technologies).
Statistical analysis of the microarray data
The raw signal intensity data were normalized using the
quantile method, and the data were transformed to a
base-2 logarithm for further statistical analysis. To
explore the difference in gene expression between
breeds at each developmental stage, we conducted a
comparative analysis with the unpaired unequal variance
t-test (Welch’s t-test) method in GeneSpring10.0 (Agi-
lent Technologies). Five t-test contrasts were performed
independently, based on the premise that no relation-
ships existed between the data at different time points.
The thresholds for significance were p < 0.05 and a fold
change of twofold or more with FDR < 0.4.
Gene ontology and functional annotation analysis
Only 1508 of the 15,008 probe set were definitive in the
Agilent Sheep Gene Expression Microarray. To further
clarify the function of the DE genes in this study, we
conducted a BLASTN search for highly homologous
human sequences (search setting: query coverage not
less than 50%, E value less than 1.00E-100). DAVID
Bioinformatics Resources (http://david.abcc.ncifcrf.gov)
[93,94] and IPA (http://www.ingenuity.com) [95] were
both used for further functional analysis to identify
which molecular events or cascades were involved dur-
ing skeletal muscle development. Significance was
expressed as a p-value, which was calculated using the
EASE score (p-values < 0.05 were considered
significant).
Quantitative real-time PCR analysis
Total RNA was used to make cDNA using the Prime-
Script
® 1st Strand cDNA Synthesis Kit (Takara Bio,
Shiga, Japan). q-Real-time PCR was performed on an
ABI 7500 instrument (Applied Biosystems, Foster City,
C A ,U S A )u s i n gt h eF a s tE v a G r e e n
® Master Mix (Bio-
tium, Hayward, CA, USA). Thermal cycling consisted of
an initial step at 95°C for 10 min followed by 40 cycles
at 95°C for 30 s and 62°C for 30 s. Fifteen DE genes
identified in the microarray experiment were selected
for validation by q-real-time PCR; RpLP0 was chosen as
the reference gene for normalization of all data because
it was expressed more stably [26-29]. Each q-real-time
PCR reaction (in 20 μl) contained 10 μlo fF a s tE v a -
Green
® Master Mix, 0.5 μl of each primer, 2 μlo fn o r -
malized template cDNA, and 7 μl water. The q-real-
time PCR measurements were performed in triplicate
on each cDNA sample (n = 31), and gene expression
was quantified relative to RpLP0 expression using the 2-
ΔΔCt method. Gene expression ratios were normalized
to the RpLP0 gene in the same sample.
Additional material
Additional file 1: Quality control and validity of the gene
expression microarray. This file contains the analytic settings using
GeneSpring10.0 (Agilent) and the detectable rate of Agilent Sheep Gene
Expression Microarray.
Additional file 2: Differentially expressed (DE) genes in skeletal
muscle between Texel and Ujumqin sheep at 70 d. For Additional
files 2-6, the t-test was employed to identify the DE genes between
Texel and Ujumqin sheep at each developmental stage using
GeneSpring 10.0 (Agilent). Only those genes with p ≤ 0.05(p-value in
Colum B) and an absolute twofold change or more(absolute FoldChange
in Colum C) were considered DE genes for further analysis. In the
“regulation” column, “up” or “down” indicates that the genes were
upregulated or downregulated in Texel fetal sheep, respectively,
compared with those in Ujumqin fetal sheep.
Additional file 3: Differentially expressed (DE) genes in skeletal
muscle between Texel and Ujumqin sheep at 85 d.
Additional file 4: Differentially expressed (DE) genes in skeletal
muscle between Texel and Ujumqin sheep at 100 d.
Additional file 5: Differentially expressed (DE) genes in skeletal
muscle between Texel and Ujumqin sheep at 120 d.
Additional file 6: Differentially expressed (DE) genes in skeletal
muscle between Texel and Ujumqin sheep at 135 d.
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